Literature DB >> 11551948

Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells.

M Jana1, X Liu, S Koka, S Ghosh, T M Petro, K Pahan.   

Abstract

The present study was undertaken to investigate the role of CD40 ligation in the expression of inducible nitric-oxide synthase (iNOS) in mouse BV-2 microglial cells and primary microglia. Ligation of CD40 alone by either cross-linking antibodies against CD40 or a recombinant CD40 ligand (CD154) was unable to induce the production of NO in BV-2 microglial cells. The absence of induction of NO production by CD40 ligation alone even in CD40-overexpressed BV-2 microglial cells suggests that a signal transduced by the ligation of CD40 alone is not sufficient to induce NO production. However, CD40 ligation markedly stimulated interferon-gamma (IFN-gamma)-mediated NO production. Ligation of CD40 in CD40-overexpressed cells further stimulated IFN-gamma-induced production of NO. This stimulation of NO production was accompanied by stimulation of the iNOS protein and mRNA. In addition to BV-2 glial cells, CD40 ligation also stimulated IFN-gamma-mediated NO production in mouse primary microglia and peritoneal macrophages. To understand the mechanism of induction/stimulation of iNOS, we investigated the roles of nuclear factor kappaB (NF-kappaB) and CCAAT/enhancer-binding protein beta (C/EBPbeta), transcription factors responsible for the induction of iNOS. IFN-gamma alone was able to induce the activation of NF-kappaB as well as C/EBPbeta. However, CD40 ligation alone induced the activation of only NF-kappaB but not of C/EBPbeta, suggesting that the activation of NF-kappaB alone by CD40 ligation is not sufficient to induce the expression of iNOS and that the activation of C/EBPbeta is also necessary for the expression of iNOS. Consistently, dominant-negative mutants of p65 (Deltap65) and C/EBPbeta (DeltaC/EBPbeta) inhibited the expression of iNOS in BV-2 microglial cells that were stimulated with the combination of IFN-gamma and CD40 ligand. Stimulation of IFN-gamma-mediated activation of NF-kappaB but not of C/EBPbeta by CD40 ligation suggests that CD40 ligation stimulates the expression of iNOS in IFN-gamma-treated BV-2 microglial cells through the stimulation of NF-kappaB activation. This study illustrates a novel role for CD40 ligation in stimulating the expression of iNOS in microglial cells, which may participate in the pathogenesis of neuroinflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551948      PMCID: PMC2041871          DOI: 10.1074/jbc.M106771200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.

Authors:  M Hecker; C Preiss; V B Schini-Kerth
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

Review 2.  A central role of CD40 ligand in the regulation of CD4+ T-cell responses.

Authors:  I S Grewal; R A Flavell
Journal:  Immunol Today       Date:  1996-09

Review 3.  Nitric oxide: a neural messenger.

Authors:  S R Jaffrey; S H Snyder
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

4.  Differential regulation by cytokines of human astrocyte nitric oxide production.

Authors:  S Hu; W S Sheng; P K Peterson; C C Chao
Journal:  Glia       Date:  1995-12       Impact factor: 7.452

5.  Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis.

Authors:  T Brenner; S Brocke; F Szafer; R A Sobel; J F Parkinson; D H Perez; L Steinman
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

Review 6.  Immune regulation by CD40 and its ligand GP39.

Authors:  T M Foy; A Aruffo; J Bajorath; J E Buhlmann; R J Noelle
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

7.  Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes.

Authors:  K Pahan; A M Namboodiri; F G Sheikh; B T Smith; I Singh
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

8.  Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.

Authors:  C A Salkowski; G Detore; R McNally; N van Rooijen; S N Vogel
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

9.  In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6.

Authors:  C E Goldring; S Reveneau; M Algarté; J F Jeannin
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

10.  Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

Authors:  I S Grewal; H G Foellmer; K D Grewal; J Xu; F Hardardottir; J L Baron; C A Janeway; R A Flavell
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  52 in total

1.  Involvement of calcitonin gene-related peptide and CCL2 production in CD40-mediated behavioral hypersensitivity in a model of neuropathic pain.

Authors:  Jennifer T Malon; Swathi Maddula; Harmony Bell; Ling Cao
Journal:  Neuron Glia Biol       Date:  2012-03-01

2.  Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

Review 3.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia.

Authors:  Xiaojuan Liu; Malabendu Jana; Subhajit Dasgupta; Sreenivas Koka; Jun He; Charles Wood; Kalipada Pahan
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

5.  Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.

Authors:  Kalipada Pahan; Malabendu Jana; Xiaojuan Liu; Bradley S Taylor; Charles Wood; Susan M Fischer
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

6.  Myelin basic protein-primed T cells induce nitric oxide synthase in microglial cells. Implications for multiple sclerosis.

Authors:  Subhajit Dasgupta; Malabendu Jana; Xiaojuan Liu; Kalipada Pahan
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

7.  Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death.

Authors:  Ik-Hyun Cho; Jinpyo Hong; Eun Cheng Suh; Jae Hwan Kim; Hyunkyoung Lee; Jong Eun Lee; Soojin Lee; Chong-Hyun Kim; Dong Woon Kim; Eun-Kyeong Jo; Kyung Eun Lee; Michael Karin; Sung Joong Lee
Journal:  Brain       Date:  2008-09-26       Impact factor: 13.501

8.  Myelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide.

Authors:  Saurav Brahmachari; Kalipada Pahan
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

9.  T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

Authors:  Ilaria Marigo; Serena Zilio; Giacomo Desantis; Bernhard Mlecnik; Andrielly H R Agnellini; Stefano Ugel; Maria Stella Sasso; Joseph E Qualls; Franz Kratochvill; Paola Zanovello; Barbara Molon; Carola H Ries; Valeria Runza; Sabine Hoves; Amélie M Bilocq; Gabriela Bindea; Emilia M C Mazza; Silvio Bicciato; Jérôme Galon; Peter J Murray; Vincenzo Bronte
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

10.  Myelin basic protein-primed T cells induce neurotrophins in glial cells via alphavbeta3 [corrected] integrin.

Authors:  Avik Roy; Xiaojuan Liu; Kalipada Pahan
Journal:  J Biol Chem       Date:  2007-09-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.